Accessibility Menu
Genus Plc logo

Genus Plc(OTC) GENSF

Market Cap$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)+109%
5 Year-54%
1 Year+21%
1 Month+0%
$31.07
+0.29%
+0.09Today
Genus Plc last closing stock price
MetricPriceDate
Last closeUSD 31.072026-06-23
Genus Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 31.072026-05-29
1 month+0%USD 31.072026-05-13
3 month-13.62%USD 35.972026-03-12
Year to date-10.88%USD 34.862025-12-29
1 year+20.9%USD 25.702025-06-13
3 year-7.6%USD 33.622023-05-23
5 year-54.43%USD 68.182021-06-24
Since inception+109.43%USD 14.832007-10-24

Genus Plc Financials at a Glance

Market Cap

$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.18B

Net Income (TTM)

£46.30M

EPS (TTM)

$0.94

P/E Ratio

32.63

Dividend

$0.44

Beta (Volatility)

0.07 (Low)

Price

$31.07

Volume

25

Open

$31.07

Previous Close

$31.07

Daily Range

$31.07 - $31.07

52-Week Range

$30.98 - $37.25

Estimated Earnings Date

Sep 10, 2026

GENSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genus Plc

Genus plc is a global leader in animal genetics, specializing in the breeding of livestock to enhance agricultural productivity. The company operates across multiple regions, including North America, Europe, and Asia, and is structured into three main segments: Genus PIC, Genus ABS, and Genus Research and Development.

Products and Services
  • Breeding pigs and boar semen for swine production
  • Bull semen and bovine embryos for dairy and beef cattle
  • Specialized technical support for agricultural producers
Growth Outlook
  • Expansion into emerging markets is expected to drive revenue growth
  • Investment in R&D aims to enhance product offerings and efficiency
  • Increasing global demand for sustainable livestock solutions supports long-term growth
Financial Highlights
  • Recent quarterly revenue of £335.5 million reflects strong market demand
  • Trailing twelve months (TTM) net income of £29.8 million indicates profitability
  • Dividend yield of 1.54% demonstrates commitment to returning value to shareholders
Genus plc has established itself as a key player in the biotechnology sector, focusing on animal genetics to meet the growing global demand for food. The company's diverse product offerings and commitment to innovation position it well for future growth. Recent financial performance highlights a solid revenue base and profitability, which may attract potential investors looking for opportunities in the agricultural biotechnology space. The focus on sustainability and efficiency in livestock production aligns with global trends, further enhancing the company's growth prospects.
AI Generated • Jul 25, 2026

Industry

Biotechnology

Sector

Health Care

Employees

3,307

CEO

Jorgen Kokke

Website

www.genusplc.com

Headquarters

Basingstoke, HM RG21 4DZ, GB

GENSF Financials

Key Financial Metrics (TTM)

Gross Margin

100.07%

Operating Margin

9.78%

Net Income Margin

7.07%

Return on Equity

9.70%

Return on Capital

5.72%

Return on Assets

5.16%

Earnings Yield

3.06%

Dividend Yield

1.40%

Payout Ratio

44.42%

Stock Overview

Market Cap

$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

66.41M

Volume

25

Avg. Volume

15.254

Financials (TTM)

Gross Profit

£947.60M

Operating Income

£70.74M

EBITDA

£170.24M

Operating Cash Flow

£102.00M

Capital Expenditure

-£26.80M

Free Cash Flow

£75.20M

Cash & ST Invst.

£43.39M

Total Debt

£260.70M

Genus Plc Performance Analysis

Genus Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30GBP 788,807,744N/A
20232023-06-30GBP 829,591,9935.2%
20242024-06-30GBP 841,961,4531.5%
20252025-06-30GBP 870,399,3313.4%
Genus Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-300.5%
Q22024-12-30100.7%
Q42025-06-30N/A
Q22025-12-31-0.3%
Genus Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30GBP 0.83N/A
20232023-06-30GBP 0.61-26.6%
20242024-06-30GBP 0.15-75.2%
20252025-06-30GBP 0.37148.6%
Genus Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-142.6%
Q22024-12-30156.3%
Q42025-06-30841.7%
Q22025-12-3199.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£335.55M

+101.2%

Gross Profit

£313.95M

+88.2%

Gross Margin

93.56%

N/A

Market Cap

$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$589.47K

N/A

Employees

3,500

N/A

Net Income

£29.80M

+341.4%

EBITDA

£57.39M

+128.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£43.39M

+3.3%

Total Debt

£260.70M

-10.7%

Accounts Receivable

£124.48M

+11.7%

Inventory

£74.19M

-23.2%

Long Term Debt

£246.10M

-10.1%

Short Term Debt

£14.60M

-21.1%

Return on Assets

5.16%

N/A

Return on Invested Capital

8.35%

N/A

Free Cash Flow

£17.60M

+1273.1%

Operating Cash Flow

£22.90M

+663.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MEOBFMesoblast Limited
$1.70+0.00%
GTBIFGreen Thumb Industries Inc.
$7.10+1.28%
ONTTFOxford Nanopore Technologies plc
$1.54+4.05%
PHMMFPharma Mar, S.A.
$86.09+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About GENSF

What is the current price of Genus Plc?

Genus Plc is trading at $31.07 per share.

What is the 52-week range for Genus Plc?

Over the past 52 weeks, Genus Plc has traded between $30.98 and $37.25.

How much debt does Genus Plc have?

As of the most recent reporting period, Genus Plc reported total debt of £364.38M.

How much cash does Genus Plc have on hand?

Genus Plc reported £65.78M in cash and cash equivalents in its most recent financial results.

What is Genus Plc’s dividend yield?

Genus Plc currently has a dividend yield of 1.40%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services